Identical to her husband, President Joe Biden, did earlier this summer time, the primary woman has examined constructive for COVID-19 in a “rebound” case after being handled with the antiviral remedy Paxlovid.
Jill Biden examined constructive by antigen testing once more on Wednesday, after testing unfavorable on Tuesday, mentioned her spokeswoman, Kelsey Donohue, in an announcement.
The Washington Post reported that the primary woman has not had new signs and is isolating in Delaware.
Jill Biden, 71, first examined constructive for the coronavirus on August 16. She started a course of Paxlovid. She has been double-vaccinated and boosted twice, and skilled delicate signs, her workplace mentioned on the time.
The president, 79, examined unfavorable Wednesday morning on an antigen check, The Submit reported. “The White Home mentioned he could be examined extra often and would masks for 10 days when indoors and in proximity to others, in accordance with steering from the Facilities for Illness Management and Prevention.”
President Biden first examined constructive on July 21, obtained Paxlovid, and had a rebound.
“Physicians have warned that individuals who obtain the antiviral treatment Paxlovid can expertise rebound infections days after initially testing unfavorable, though knowledge on the frequency of the incidence and its long-term results stay unclear,” the newspaper reported.
Early reviews indicated between 1% and a pair of% of individuals handled with Paxlovid skilled signs once more. One other research in June put the determine at 6%. Medical doctors are figuring out if sufferers ought to obtain remedy for an extended interval to forestall recurrence.